Harkin A - Search Results

1

Amitriptyline protects against TNF-α-induced atrophy and reduction in synaptic markers via a Trk-dependent mechanism.

O'Neill E, Kwok B, Day JS, Connor TJ, Harkin A. O'Neill E, et al. Among authors: harkin a. Pharmacol Res Perspect. 2016 Mar 8;4(2):e00195. doi: 10.1002/prp2.195. eCollection 2016 Apr. Pharmacol Res Perspect. 2016. PMID: 27069625 Free PMC article.

2

Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression.

Harkin A, Kelly JP, McNamara M, Connor TJ, Dredge K, Redmond A, Leonard BE. Harkin A, et al. Eur J Pharmacol. 1999 Jan 8;364(2-3):123-32. doi: 10.1016/s0014-2999(98)00838-3. Eur J Pharmacol. 1999. PMID: 9932714

3

Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the rat.

Connor TJ, Kelliher P, Harkin A, Kelly JP, Leonard BE. Connor TJ, et al. Among authors: harkin a. Eur J Pharmacol. 1999 Aug 27;379(2-3):125-33. doi: 10.1016/s0014-2999(99)00492-6. Eur J Pharmacol. 1999. PMID: 10497898

4

Olfactory bulbectomy provokes a suppression of interleukin-1beta and tumour necrosis factor-alpha production in response to an in vivo challenge with lipopolysaccharide: effect of chronic desipramine treatment.

Connor TJ, Harkin A, Kelly JP, Leonard BE. Connor TJ, et al. Among authors: harkin a. Neuroimmunomodulation. 2000;7(1):27-35. doi: 10.1159/000026417. Neuroimmunomodulation. 2000. PMID: 10601816

5

Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test.

Connor TJ, Kelliher P, Shen Y, Harkin A, Kelly JP, Leonard BE. Connor TJ, et al. Among authors: harkin a. Pharmacol Biochem Behav. 2000 Apr;65(4):591-7. doi: 10.1016/s0091-3057(99)00192-6. Pharmacol Biochem Behav. 2000. PMID: 10764911

6

Varying responses to the rat forced-swim test under diurnal and nocturnal conditions.

Kelliher P, Connor TJ, Harkin A, Sanchez C, Kelly JP, Leonard BE. Kelliher P, et al. Among authors: harkin a. Physiol Behav. 2000 Jun 1-15;69(4-5):531-9. doi: 10.1016/s0031-9384(00)00213-4. Physiol Behav. 2000. PMID: 10913793

7

Methylenedioxymethamphetamine-induced suppression of interleukin-1beta and tumour necrosis factor-alpha is not mediated by serotonin.

Connor TJ, Dennedy MC, Harkin A, Kelly JP. Connor TJ, et al. Among authors: harkin a. Eur J Pharmacol. 2001 Apr 20;418(1-2):147-52. doi: 10.1016/s0014-2999(01)00928-1. Eur J Pharmacol. 2001. PMID: 11334877

8

Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats.

Harkin A, Connor TJ, Mulrooney J, Kelly JP, Leonard BE. Harkin A, et al. Life Sci. 2001 Feb 9;68(12):1367-82. doi: 10.1016/s0024-3205(00)01039-0. Life Sci. 2001. PMID: 11388689

9

Physiological and behavioral responses to stress: what does a rat find stressful?

Harkin A, Connor TJ, O'Donnell JM, Kelly JP. Harkin A, et al. Lab Anim (NY). 2002 Apr;31(4):42-50. doi: 10.1038/5000150. Lab Anim (NY). 2002. PMID: 11927961 No abstract available.

10

Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors.

Harkin A, Connor TJ, Walsh M, St John N, Kelly JP. Harkin A, et al. Neuropharmacology. 2003 Apr;44(5):616-23. doi: 10.1016/s0028-3908(03)00030-3. Neuropharmacology. 2003. PMID: 12668047

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters